A man wearing a mask holds up a positive COVID-19 rapid antigen test.

...

Amanda Greenwood

By Amanda Greenwood

Associate News Editor

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


Health officials are closely monitoring the spread of a newly identified strain of COVID‑19 known as BA.3.2, a heavily mutated offshoot of the Omicron lineage that has now been detected across 25 U.S. states and in at least 23 countries, according to data from the Centers for Disease Control and Prevention (CDC).

The New COVID Strain

BA.3.2, which was first identified in a respiratory sample collected in South Africa in November 2024, has drawn attention from scientists because of the unusually high number of genetic changes it carries.

Read More on News

The variant contains an estimated 70 to 75 mutations in its spike protein—significantly more than the JN.1‑lineage variants targeted by current COVID‑19 vaccines—raising concerns that the virus may be better at slipping past existing immune defenses, like the vaccine.

A sign for a gas station and free COVID vaccines in Colorado in 2022.

...

Where BA.3.2 Has Been Found in the United States

According to the CDC, BA.3.2 has been identified through traveler testing, clinical samples, and wastewater surveillance in the following 25 U.S. states:

Public health experts caution that the true footprint of the variant may be wider, as not all states conduct extensive genomic sequencing or wastewater surveillance.

Countries Reporting the Variant

Internationally, BA.3.2 has now been reported in at least 23 countries, based on CDC surveillance data, which has been cited by multiple outlets.

While the CDC has not released a full country‑by‑country breakdown, it has confirmed detections in the following global nations:

The CDC did caveat that surveillance gaps in some regions mean the true number of affected countries could be higher.

Symptoms and Severity

So far, BA.3.2 does not appear to cause more severe illness than earlier Omicron variants.

Reported symptoms have largely mirrored existing COVID‑19 strains and include cough, fever, fatigue, sore throat, headache, muscle aches, and congestion. Some cases have reported gastrointestinal symptoms or skin rashes, though these remain uncommon.

Health officials stress that vaccines are still expected to provide strong protection against severe illness, hospitalization, and death.

Why Scientists Are Watching BA.3.2

The main concern surrounding BA.3.2 lies in its mutation profile. Laboratory studies cited by the CDC suggest the variant may partially evade immunity from prior infection or vaccination, highlighting the importance of continued genomic monitoring and possible vaccine updates in the future.

For now, public health agencies emphasize vigilance—not panic.

The variant remains a small fraction of COVID-19 cases, but its steady spread has placed it firmly on the radar of scientists tracking the virus’ ongoing evolution.

In a polarized era, the center is dismissed as bland. At Newsweek, ours is different: The Courageous Center—it's not "both sides," it's sharp, challenging and alive with ideas. We follow facts, not factions. If that sounds like the kind of journalism you want to see thrive, we need you.

When you become a Newsweek Member, you support a mission to keep the center strong and vibrant. Members enjoy: Ad-free browsing, exclusive content and editor conversations. Help keep the center courageous. Join today.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines